Nautilus Biotechnology
Dr. Parag Mallick is an Associate Professor at Stanford University, and an interdisciplinary scientist, who has developed multi-scale approaches to accelerate the discovery of diagnostic and prognostic protein biomarkers. Parag trained with pioneering researcher Ruedi Aebersold in clinical proteomics and systems biology at the Institute for Systems Biology. Parag holds BS degrees in Computer Science & Biochemistry and a PhD in Chemistry & Biochemistry from UCLA. He has over 75 publications and holds patents in the fields of artificial intelligence, proteomics technology, biomarker development, and nanotechnology.
This person is not in any offices
Nautilus Biotechnology
Nautilus (Nasdaq: NAUT) is a company with a vision to revolutionize biomedicine by unlocking the complexity of the human proteome. They are driven to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across biomedical research and drug discovery.